Last update 06 Dec 2024
NBTX-001
Last update 06 Dec 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms NBTX 001, NBTX001 |
Target |
Mechanism NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization  Nobilis Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with NBTX-001A Double-Blind, Randomized, Placebo-Controlled Trial of Xenon Inhalation for Treatment of Patients With Posttraumatic Stress Disorder
Comparative Controlled Study of Analgesic, Antiasthenic and Anti-Anxiety Effects of Xenon in Patients With Parkinson's Disease
100 Clinical Results associated with NBTX-001
Login to view more data
100 Translational Medicine associated with NBTX-001
Login to view more data
100 Patents (Medical) associated with NBTX-001
Login to view more data
100 Deals associated with NBTX-001
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Stress Disorders, Post-Traumatic | Phase 3 | - | Nobilis Therapeutics, Inc.Startup | 01 Jun 2021 |
| Anxiety Disorders | Phase 1 | RU | Nobilis Therapeutics, Inc.Startup | 15 Dec 2019 |
| Parkinson Disease | Phase 1 | RU | Nobilis Therapeutics, Inc.Startup | 15 Dec 2019 |
| Panic Disorder | Phase 1 | RU | Nobilis Therapeutics, Inc.Startup | - |
| Obsessive-Compulsive Disorder | Preclinical | US | Nobilis Therapeutics, Inc.Startup | 24 Nov 2023 |
| Autism Spectrum Disorder | Preclinical | US | Nobilis Therapeutics, Inc.Startup | 09 Apr 2018 |
| Irritable Bowel Syndrome | Preclinical | US | Nobilis Therapeutics, Inc.Startup | 12 Mar 2018 |
| Alzheimer Disease | Preclinical | US | Nobilis Therapeutics, Inc.Startup | 07 Mar 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free